Review



snp cyp2c19 c 30634130 30  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Thermo Fisher snp cyp2c19 c 30634130 30
    Percentage of PEC reduction and EREFS score reduction from baseline to after eight-week treatment according to genotypes and phenotypes.
    Snp Cyp2c19 C 30634130 30, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/snp+cyp2c19+c+30634130+30/SNP+CYP2C19%2C+C__30634130_30/pmc11011338-93-5--1
    Average 93 stars, based on 1 article reviews
    snp cyp2c19 c 30634130 30 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis"

    Article Title: Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms25073685

    Percentage of PEC reduction and EREFS score reduction from baseline to after eight-week treatment according to genotypes and phenotypes.
    Figure Legend Snippet: Percentage of PEC reduction and EREFS score reduction from baseline to after eight-week treatment according to genotypes and phenotypes.

    Techniques Used:

    Genetic variants genotyped.
    Figure Legend Snippet: Genetic variants genotyped.

    Techniques Used: Variant Assay, TaqMan Assay

    Related Articles

    Variant Assay:

    Article Title: Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis
    Article Snippet: , rs41291556 , *8 , C__30634130_30 , NG_008384.3:g.17736T>C.

    Article Title: Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
    Article Snippet: , , *8 , 12711T > C , rs41291556 , C__30634130_30 , c.358T > C , p.Trp120Arg.

    TaqMan Assay:

    Article Title: Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis
    Article Snippet: , rs41291556 , *8 , C__30634130_30 , NG_008384.3:g.17736T>C.

    Article Title: Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
    Article Snippet: , , *8 , 12711T > C , rs41291556 , C__30634130_30 , c.358T > C , p.Trp120Arg.

    Comparison:

    Article Title: Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis
    Article Snippet: , rs41291556 , *8 , C__30634130_30 , NG_008384.3:g.17736T>C.

    Article Title: Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
    Article Snippet: , , *8 , 12711T > C , rs41291556 , C__30634130_30 , c.358T > C , p.Trp120Arg.



    Similar Products

    93
    Thermo Fisher snp cyp2c19 c 30634130 30
    Percentage of PEC reduction and EREFS score reduction from baseline to after eight-week treatment according to genotypes and phenotypes.
    Snp Cyp2c19 C 30634130 30, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/snp+cyp2c19+c+30634130+30/SNP+CYP2C19%2C+C__30634130_30/pmc11011338-93-5--1
    Average 93 stars, based on 1 article reviews
    snp cyp2c19 c 30634130 30 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Percentage of PEC reduction and EREFS score reduction from baseline to after eight-week treatment according to genotypes and phenotypes.

    Journal: International Journal of Molecular Sciences

    Article Title: Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis

    doi: 10.3390/ijms25073685

    Figure Lengend Snippet: Percentage of PEC reduction and EREFS score reduction from baseline to after eight-week treatment according to genotypes and phenotypes.

    Article Snippet: , rs41291556 , *8 , C__30634130_30 , NG_008384.3:g.17736T>C.

    Techniques:

    Genetic variants genotyped.

    Journal: International Journal of Molecular Sciences

    Article Title: Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis

    doi: 10.3390/ijms25073685

    Figure Lengend Snippet: Genetic variants genotyped.

    Article Snippet: , rs41291556 , *8 , C__30634130_30 , NG_008384.3:g.17736T>C.

    Techniques: Variant Assay, TaqMan Assay